GenMark Diagnostics Debt to Equity Ratio 2010-2018 | GNMK

Current and historical debt to equity ratio values for GenMark Diagnostics (GNMK) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. GenMark Diagnostics debt/equity for the three months ending December 31, 2018 was 1.07.
GenMark Diagnostics Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2018-12-31 $0.04B $0.03B 1.07
2018-09-30 $0.03B $0.04B 0.69
2018-06-30 $0.01B $0.05B 0.19
2018-03-31 $0.02B $0.06B 0.24
2017-12-31 $0.02B $0.07B 0.28
2017-09-30 $0.01B $0.08B 0.12
2017-06-30 $0.02B $0.09B 0.16
2017-03-31 $0.01B $0.03B 0.45
2016-12-31 $0.01B $0.04B 0.31
2016-09-30 $0.01B $0.05B 0.30
2016-06-30 $0.02B $0.03B 0.59
2016-03-31 $0.01B $0.04B 0.25
2015-12-31 $0.01B $0.05B 0.20
2015-09-30 $0.01B $0.05B 0.18
2015-06-30 $0.01B $0.06B 0.15
2015-03-31 $0.01B $0.07B 0.13
2014-12-31 $0.00B $0.08B 0.00
2014-09-30 $0.00B $0.09B 0.00
2014-06-30 $0.00B $0.09B 0.00
2014-03-31 $0.00B $0.10B 0.00
2013-12-31 $0.00B $0.11B 0.00
2013-09-30 $0.00B $0.12B 0.00
2013-06-30 $0.00B $0.05B 0.00
2013-03-31 $0.00B $0.05B 0.00
2012-12-31 $0.00B $0.06B 0.00
2012-09-30 $0.00B $0.06B 0.00
2012-06-30 $0.00B $0.07B 0.00
2012-03-31 $0.00B $0.03B 0.02
2011-12-31 $0.00B $0.03B 0.02
2011-09-30 $0.00B $0.04B 0.02
2011-06-30 $0.00B $0.04B 0.03
2011-03-31 $0.00B $0.02B 0.13
2010-12-31 $0.00B $0.02B 0.00
2010-09-30 $0.00B $0.02B 0.00
2010-06-30 $0.00B $0.03B 0.00
2010-03-31 $0.00B $0.00B 0.00
2009-12-31 $0.00B $0.00B 0.00
2009-09-30 $0.00B $0.00B 0.00
2009-06-30 $0.00B $0.00B 0.00
2009-03-31 $0.00B $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.408B $0.071B
GenMark Diagnostics, Inc. is a molecular diagnostics company focused on developing and commercializing its proprietary eSensor(R) detection technology. The eSensor? XT-8 system is the second generation in GenMark Dx's eSensor? platform, utilizing electrochemical detection technology to detect nucleic acids on a microarray. The XT-8 System enables multiplex detection of DNA and RNA targets. The Company has developed four diagnostic tests for use with its XT-8 System. Its Cystic Fibrosis Genotyping Test, which detects pre-conception risks of cystic fibrosis, and its Warfarin Sensitivity Test, which determines an individual's ability to metabolize the oral anticoagulant warfarin, have received FDA clearance. It has also developed a Respiratory Viral Panel Test, which detects the presence of major respiratory viruses, and a Thrombosis Risk Test, which detects an individual's increased risk of blood clots. GenMark Diagnostics, Inc. is based in Pasadena, California.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $105.149B 23.70
Intuitive Surgical (ISRG) United States $64.544B 60.29
Edwards Lifesciences (EW) United States $39.661B 40.62
Fresenius Medical Care AG KGaA (FMS) Germany $24.173B 16.55
IDEXX Laboratories (IDXX) United States $18.555B 50.53
ABIOMED (ABMD) United States $15.025B 99.18
Teleflex (TFX) United States $13.856B 30.38
Hologic (HOLX) United States $13.744B 20.78
DexCom (DXCM) United States $13.154B 503.96
Varian Medical Systems (VAR) United States $12.307B 30.74
STERIS (STE) United Kingdom $10.424B 26.79
Masimo (MASI) United States $7.034B 43.79
Penumbra (PEN) United States $5.275B 298.45
Integra LifeSciences Holdings (IART) United States $4.747B 23.02
Globus Medical (GMED) United States $4.684B 28.43
LivaNova (LIVN) United Kingdom $4.643B 28.38
Tandem Diabetes Care (TNDM) United States $4.116B 0.00
Wright Medical Group (WMGI) Netherlands $4.048B 0.00
Cantel Medical (CMD) United States $2.797B 27.81
Integer Holdings (ITGR) United States $2.795B 22.80
Glaukos (GKOS) United States $2.642B 0.00
Inogen (INGN) United States $2.088B 41.61
AVANOS MEDICAL, INC (AVNS) United States $2.041B 22.17
OPKO Health (OPK) United States $1.551B 0.00
Nevro (NVRO) United States $1.349B 0.00
Tactile Systems Technology (TCMD) United States $1.170B 222.11
Pacific Biosciences Of California (PACB) United States $1.110B 0.00
CryoLife (CRY) United States $1.099B 118.44
Accelerate Diagnostics (AXDX) United States $1.089B 0.00
Luminex (LMNX) United States $1.072B 48.98
ORTHOFIX MEDICAL INC (OFIX) United States $1.071B 29.11
Intersect ENT (XENT) United States $1.036B 0.00
Natus Medical (BABY) United States $0.913B 19.03
Mesa Laboratories (MLAB) United States $0.898B 36.74
Veracyte (VCYT) United States $0.898B 0.00
AxoGen (AXGN) United States $0.837B 0.00
AngioDynamics (ANGO) United States $0.814B 26.40
ViewRay (VRAY) United States $0.790B 0.00
OrthoPediatrics (KIDS) United States $0.661B 0.00
Quotient (QTNT) Switzerland $0.613B 0.00
Fluidigm (FLDM) United States $0.543B 0.00
TransEnterix (TRXC) United States $0.510B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.475B 50.03
Si-Bone (SIBN) United States $0.459B 0.00
Accuray (ARAY) United States $0.410B 0.00
Corindus Vascular Robotics (CVRS) United States $0.385B 0.00
Pulse Biosciences (PLSE) United States $0.378B 0.00
RTI Surgical (RTIX) United States $0.370B 54.00
Neuronetics (STIM) United States $0.296B 0.00
IRadimed (IRMD) United States $0.281B 59.42
SeaSpine Holdings (SPNE) United States $0.273B 0.00
Sientra (SIEN) United States $0.269B 0.00
Nuvectra (NVTR) United States $0.225B 0.00
CRH Medical (CRHM) Canada $0.210B 48.67
Helius Medical Technologies (HSDT) United States $0.160B 0.00
Ekso Bionics Holdings (EKSO) United States $0.159B 0.00
Biosig Technologies (BSGM) United States $0.137B 0.00
Sensus Healthcare (SRTS) United States $0.130B 0.00
ConforMIS (CFMS) United States $0.127B 0.00
Alphatec Holdings (ATEC) United States $0.119B 0.00
T2 Biosystems (TTOO) United States $0.118B 0.00
Second Sight Medical Products (EYES) United States $0.104B 0.00
Vermillion (VRML) United States $0.100B 0.00
SOLITON INC (SOLY) $0.091B 0.00
EDAP TMS (EDAP) France $0.086B 0.00
Apollo Endosurgery (APEN) United States $0.073B 0.00
Titan Medical (TMDI) Canada $0.072B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.068B 0.00
Ra Medical Systems (RMED) United States $0.051B 0.00
Avinger (AVGR) United States $0.044B 0.00
Electromed (ELMD) United States $0.044B 22.83
Xtant Medical Holdings (XTNT) United States $0.041B 0.00
OBALON THERPTCS (OBLN) United States $0.039B 0.00
Restoration Robotics (HAIR) United States $0.035B 0.00
Microbot Medical (MBOT) United States $0.034B 0.00
Viveve Medical (VIVE) United States $0.030B 0.00
PAVmed (PAVM) United States $0.029B 0.00
Navidea Biopharmaceuticals (NAVB) United States $0.026B 0.00
Atossa Genetics (ATOS) United States $0.025B 0.00
Lianluo Smart (LLIT) China $0.025B 0.00
DarioHealth (DRIO) Israel $0.023B 0.00
Bioanalytical Systems (BASI) United States $0.019B 63.02
Dynatronics (DYNT) United States $0.018B 0.00
ReWalk Robotics (RWLK) Israel $0.017B 0.00
Presbia (LENS) Ireland $0.016B 0.00
ENDRA Life Sciences (NDRA) United States $0.016B 0.00
Nanovibronix (NAOV) United States $0.015B 0.00
Neovasc (NVCN) Canada $0.013B 0.00
Micron Solutions (MICR) United States $0.009B 0.00
Allied Healthcare Products (AHPI) United States $0.007B 0.00
Cesca Therapeutics (KOOL) United States $0.007B 0.00
InspireMD (NSPR) Israel $0.007B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.005B 0.00
Sunshine Heart Inc (CHFS) United States $0.002B 0.00
Check-Cap (CHEK) Israel $0.000B 0.00